CD80 and rheumatoid arthritis: In rheumatoid arthritis, pro-inflammatory CD80+ macrophages sustain immune imbalance; EVs engineered to deliver methotrexate reprogram them toward anti-inflammatory phenotypes, enhance Treg differentiation, and suppress Th1 responses (25).